Aesthetic pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for the treatment of wrinkles in the décolleté using regenerative biostimulator RADIESSE.
The indication applies to patients aged 22 years and above, marking the fourth approved use for the product. Designed to address visible signs of ageing at their source, RADIESSE works by stimulating the production of collagen, elastin and other key structural proteins, thereby improving skin firmness and overall quality, shares the company.
Samantha Kerr, chief scientific officer at Merz Aesthetics, said, “The décolleté is one of the most visible – and often earliest – areas to show signs of ageing. Frequently overlooked in both skincare routines and aesthetic treatments, this delicate region can benefit significantly from RADIESSE, helping to improve the appearance of wrinkles and enhance overall skin quality.”